539 related articles for article (PubMed ID: 28668513)
1. Toll-like receptors, NF-κB, and IL-27 mediate adenosine A2A receptor signaling in BTBR T
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Al-Ayadhi LY; Attia SM
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):184-191. PubMed ID: 28668513
[TBL] [Abstract][Full Text] [Related]
2. Adenosine A2A receptor signaling affects IL-21/IL-22 cytokines and GATA3/T-bet transcription factor expression in CD4
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Almutairi MM; Attia SM
J Neuroimmunol; 2017 Oct; 311():59-67. PubMed ID: 28807491
[TBL] [Abstract][Full Text] [Related]
3. Adenosine A2A receptor modulates neuroimmune function through Th17/retinoid-related orphan receptor gamma t (RORγt) signaling in a BTBR T
Ansari MA; Nadeem A; Attia SM; Bakheet SA; Raish M; Ahmad SF
Cell Signal; 2017 Aug; 36():14-24. PubMed ID: 28438638
[TBL] [Abstract][Full Text] [Related]
4. Activation of adenosine A2A receptor signaling regulates the expression of cytokines associated with immunologic dysfunction in BTBR T
Ansari MA; Attia SM; Nadeem A; Bakheet SA; Raish M; Khan TH; Al-Shabanah OA; Ahmad SF
Mol Cell Neurosci; 2017 Jul; 82():76-87. PubMed ID: 28465254
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol Improves Neuroimmune Dysregulation Through the Inhibition of Neuronal Toll-Like Receptors and COX-2 Signaling in BTBR T
Ahmad SF; Ansari MA; Nadeem A; Alzahrani MZ; Bakheet SA; Attia SM
Neuromolecular Med; 2018 Mar; 20(1):133-146. PubMed ID: 29468499
[TBL] [Abstract][Full Text] [Related]
6. Immune Alterations in CD8
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Mohammad R; Attia SM
Mol Neurobiol; 2018 Mar; 55(3):2603-2616. PubMed ID: 28421534
[TBL] [Abstract][Full Text] [Related]
7. The adenosine A
Amodeo DA; Cuevas L; Dunn JT; Sweeney JA; Ragozzino ME
Autism Res; 2018 Feb; 11(2):223-233. PubMed ID: 29193861
[TBL] [Abstract][Full Text] [Related]
8. Lead (Pb) exposure exacerbates behavioral and immune abnormalities by upregulating Th17 and NF-κB-related signaling in BTBR T
Almutairi MM; Nadeem A; Ansari MA; Bakheet SA; Attia SM; Albekairi TH; Alhosaini K; Algahtani M; Alsaad AMS; Al-Mazroua HA; Ahmad SF
Neurotoxicology; 2022 Jul; 91():340-348. PubMed ID: 35760230
[TBL] [Abstract][Full Text] [Related]
9. Protection by tyrosine kinase inhibitor, tyrphostin AG126, through the suppression of IL-17A, RORγt, and T-bet signaling, in the BTBR mouse model of autism.
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alshammari MA; Attia SM
Brain Res Bull; 2018 Sep; 142():328-337. PubMed ID: 30172736
[TBL] [Abstract][Full Text] [Related]
10. A potent and selective CXCR2 antagonist improves neuroimmune dysregulation through the inhibition of NF-κB and notch inflammatory signaling in the BTBR mouse model of autism.
Alomar HA; Ansari MA; Nadeem A; Attia SM; Bakheet SA; Al-Mazroua HA; Hussein MH; Alqarni SA; Ahmad SF
J Neuroimmunol; 2023 Apr; 377():578069. PubMed ID: 36931207
[TBL] [Abstract][Full Text] [Related]
11. The potent immunomodulatory compound VGX-1027 regulates inflammatory mediators in CD4
Ahmad SF; Nadeem A; Ansari MA; Bakheet SA; Alasmari F; Alasmari AF; Al-Kharashi LA; Al-Qahtani QH; Attia SM
Life Sci; 2019 Nov; 237():116930. PubMed ID: 31610190
[TBL] [Abstract][Full Text] [Related]
12. The Stat3 inhibitor, S3I-201, downregulates lymphocyte activation markers, chemokine receptors, and inflammatory cytokines in the BTBR T
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alanazi AZ; Alsanea S; As Sobeai HM; Almutairi MM; Mahmood HM; Attia SM
Brain Res Bull; 2019 Oct; 152():27-34. PubMed ID: 31299319
[TBL] [Abstract][Full Text] [Related]
13. Cadmium exposure exacerbates immunological abnormalities in a BTBR T
Albekairi TH; Alanazi MM; Ansari MA; Nadeem A; Attia SM; Bakheet SA; Al-Mazroua HA; Aldossari AA; Almanaa TN; Alwetaid MY; Alqinyah M; Alnefaie HO; Ahmad SF
J Neuroimmunol; 2024 Jan; 386():578253. PubMed ID: 38064869
[TBL] [Abstract][Full Text] [Related]
14. Methylmercury chloride exposure aggravates proinflammatory mediators and Notch-1 signaling in CD14
Ahmad SF; Bakheet SA; Ansari MA; Nadeem A; Alobaidi AF; Attia SM; Alhamed AS; Aldossari AA; Mahmoud MA
Neurotoxicology; 2021 Jan; 82():9-17. PubMed ID: 33166615
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol attenuates pro-inflammatory cytokines and activation of JAK1-STAT3 in BTBR T
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alzahrani MZ; Alshammari MA; Alanazi WA; Alasmari AF; Attia SM
Eur J Pharmacol; 2018 Jun; 829():70-78. PubMed ID: 29654783
[TBL] [Abstract][Full Text] [Related]
16. Adenosine A
Wang YQ; Li R; Wang DR; Cherasse Y; Zhang Z; Zhang MQ; Lavielle O; McEown K; Schiffmann SN; de Kerchove d'Exaerde A; Qu WM; Lazarus M; Huang ZL
Brain Struct Funct; 2017 Apr; 222(3):1351-1366. PubMed ID: 27485749
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol treatment attenuates chemokine receptor expression in the BTBR T+tf/J mouse model of autism.
Bakheet SA; Alzahrani MZ; Nadeem A; Ansari MA; Zoheir KMA; Attia SM; Al-Ayadhi LY; Ahmad SF
Mol Cell Neurosci; 2016 Dec; 77():1-10. PubMed ID: 27693537
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol Ameliorates Dysregulation of Th1, Th2, Th17, and T Regulatory Cell-Related Transcription Factor Signaling in a BTBR T + tf/J Mouse Model of Autism.
Bakheet SA; Alzahrani MZ; Ansari MA; Nadeem A; Zoheir KMA; Attia SM; Al-Ayadhi LY; Ahmad SF
Mol Neurobiol; 2017 Sep; 54(7):5201-5212. PubMed ID: 27578011
[TBL] [Abstract][Full Text] [Related]
19. NF-κB enhances hypoxia-driven T-cell immunosuppression via upregulation of adenosine A(2A) receptors.
Bruzzese L; Fromonot J; By Y; Durand-Gorde JM; Condo J; Kipson N; Guieu R; Fenouillet E; Ruf J
Cell Signal; 2014 May; 26(5):1060-7. PubMed ID: 24486403
[TBL] [Abstract][Full Text] [Related]
20. Aflatoxin B
Almanaa TN; Alwetaid MY; Bakheet SA; Attia SM; Ansari MA; Nadeem A; Ahmad SF
J Neuroimmunol; 2024 Jun; 391():578365. PubMed ID: 38723577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
